INSTIL BIO
Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes for the treatment of solid tumor cancers. It is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its candidate and the first-in-human study of its next-generation engineered TIL.
INSTIL BIO
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2018-01-01
Address:
Dallas, Texas, United States
Country:
United States
Website Url:
http://www.instilbio.com
Total Employee:
101+
Status:
Active
Total Funding:
200.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
Innovative BioTherapies
Innovative BioTherapies is a biotechnology company that develops medical devices to solve unmet medical needs.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Current Employees Featured
Founder
Stock Details
Investors List
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series C - Instil Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2022-09-09 | Dallas-based Instil Bio hires biotech veteran as new COO |
Official Site Inspections
http://www.instilbio.com Semrush global rank: 2.67 M Semrush visits lastest month: 6.26 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Instil Bio"
About - Instil Bio
Instil Bio is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. Instilโs lead asset, SYN-2510, is a novel and differentiated PD-L1xVEGF bispecific โฆSee details»
Instil Bio - Crunchbase Company Profile & Funding
Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes for the treatment of solid tumor cancers. It is advancing its proprietary manufacturing expertise, technology, and โฆSee details»
Working At Instil Bio: Company Overview and Culture - Zippia
Mar 14, 2024 instilbio.com. Organization Type. Public. CEO. Bronson Crouch. Social Media. Instil Bio is a biotechnology company that develops cell therapies for solid tumor cures. The โฆSee details»
Instil Bio - Overview, News & Similar companies | ZoomInfo.com
May 27, 2024 Instil Bio contact info: Phone number: (972) 499-3350 Website: www.instilbio.com What does Instil Bio do? Instil Bio, Inc is a global, clinical-stage cell therapy company โฆSee details»
Instil Bio Company Profile | Management and Employees List
Www.instilbio.com Instil Bio Profile and History Instil Bio, Inc is a global, clinical-stage cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of cancer.See details»
Instil Bio Company Profile 2024: Stock Performance
Instil Bio General Information Description. Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of โฆSee details»
Instil Bio - LinkedIn
Instil Bio is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. Instil seeks to in-license/acquire and develop novel therapeutic candidates in ...See details»
Corporate Governance - Instil Bio
The Investor Relations website contains information about Instil Bio's business for stockholders, potential investors, and financial analysts.See details»
Instil Bio Information - RocketReach
Instil Bio is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. Instil seeks to in-license/acquire and develop novel therapeutic candidates in โฆSee details»
Instil Bio Announces Voluntary Pause of Enrollment in Ongoing โฆ
Oct 31, 2022 We have assembled a world-class technical operations organization and leadership team to address the challenges associated with manufacturing these therapies.โ ... โฆSee details»
Instil Bio - Craft
Oct 29, 2024 Instil Bio (formerly Immetacyte, Cellular Therapeutics) is an immuno-oncology company that specializes in cell therapies. Its technology platform is based on the use of โฆSee details»
Instil Bio Announces Strategic Update - GlobeNewswire
Jan 16, 2024 For more information visit www.instilbio.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities โฆSee details»
Instil Bio Announces Strategic Update - Yahoo Finance
DALLAS, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (โInstilโ or the โCompanyโ) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor โฆSee details»
Associate Director of Manufacturing Technical Services
ABOUT InstilBioInstilBio Inc, a cell therapy company focused on solid tumors, has recently acquired Immetacyte Ltd. InstilBio is developing patient specific immunotherapies in oncology, โฆSee details»
Instil Bio Reports First Quarter 2021 Financial Results and Provides ...
May 13, 2021 For more information visit www.instilbio.com and LinkedIn. Forward-Looking Statements. This press release contains forward-looking statements within the meaning of the โฆSee details»
Instil Bio (Nasdaq:TIL) - Stock Price, News & Analysis - Simply Wall St
5 days ago instilbio.com: Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor โฆSee details»
News Release - Instil Bio
Nov 14, 2022 For more information visit www.instilbio.com. Forward-Looking Statements. This press release contains forward-looking statements within the meaning of the Private Securities โฆSee details»
Instil Bio and ImmuneOnco Announce Global Registrational
Sep 16, 2024 Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple โฆSee details»
Pipeline - Instil Bio
NSCLC: non-small cell lung cancer; FRฮฑ: Folate Receptor ฮฑ; PD-L1: Programmed death-ligand 1; VEGF: Vascular endothelial growth factor; Cytotoxic T-lymphocyte associated protein 4;See details»